Dallas, Texas (PRWEB) December 24, 2012
This report provides a detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes therapeutic categories analysis and CMO growth in the region, and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Asia-Pacific Active Pharmaceutical Ingredients market, covering all of the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by our team of industry experts.
Asia-Pacific is the second largest regional market for APIs by revenue in the world. The Asia-Pacific active pharmaceutical ingredients market revenue held a share of around 28.3% of the global API market in 2011, with the global revenue standing at $108,613m. Total revenue generated by the Asia-Pacific API market was $30,693m in 2011, and is expected to grow at a CAGR of 5.6% to reach $63.8 billion by 2017. This will be supported by healthy demand from the biotech and generic API sectors.
Market revenue data for APIs from 2005 to 2011 and forecasts for six years to 2017. Active Pharmaceutical Ingredients APIs market in key countries in the region, including Japan, China, South Korea and India. API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region and drivers of the AP
Copyright©2012 Vocus, Inc.
All rights reserved